Volare's €15M Pori plant tests insect protein's
Volare 01 reportedly hit its €15M budget, but terms of the €7.1M new money are undisclosed and unit economics are unpublished.
Volare's Pori plant is a real operational milestone, not yet proof of a business. Volare 01 reportedly reached its €15 million budget, and Springvest carried a further €7.1 million, but financing terms, utilisation and unit costs remain unpublished, so the margin question stays open.
Traction Desk · 3 min read- Volare 01 in Pori, Finland, is a 10,000 m² plant targeting up to 5,000 tonnes of insect protein a year, according to Tech.eu.
- Delivery within a €15 million budget is a company claim relayed by Tech.eu; no independent audit is cited.
- The €7.1 million new funding came through Springvest with Maki.vc among the backers; whether it is equity, debt or a grant is not stated in the coverage reviewed.
- Utilisation, cost per tonne and margin decide whether the model works, and none has been published.
- Trade press has reported a larger €26 million figure for the same company, so the total raised should be confirmed with Volare before it is repeated.
Volare has finished its first industrial plant, and the interesting question is the arithmetic behind the ribbon-cutting. Tech.eu reports that Volare 01, in Pori, Finland, covers 10,000 m² and targets up to 5,000 tonnes of insect protein a year. Volare says it was delivered within a €15 million budget and that it has secured €7.1 million in new funding. A finished building is the easy half of a bet; the hard half is margin at scale.
What Volare says it built
According to Tech.eu, Volare 01 was fitted into an existing industrial site, runs on electricity and is designed to be operated by a small crew per shift. Volare presents it as a large step up from its earlier demonstration plant. These are the company's own figures as relayed by Tech.eu. The coverage reviewed contains no independent engineering or audit confirmation of throughput, staffing or energy use, so they should be read as targets.
The €7.1M raise is thin on terms
Tech.eu reports the €7.1 million came through Springvest, with new and existing investors including Maki.vc, to support ramp-up and further facilities. The article does not say whether the money is equity, debt or a grant, and it gives no valuation, so the terms should be treated as undisclosed. Next to the €15 million reportedly spent on the plant, this reads as a scale-up top-up rather than a transformative round.
Another funding figure is in circulation
Salmon Business headlined a €26 million investment for Volare's industrial rollout, a larger number than the €7.1 million in Tech.eu's report. The two figures may describe different scopes, such as a cumulative total against one tranche, but the coverage reviewed does not reconcile them. Until Volare or its investors say which is which, any single headline number for capital raised should be attributed to its outlet rather than stated as settled.
Demand evidence is partial
Tech.eu says a significant share of capacity is already sold and describes Skretting, an aquafeed company, as an early tester and offtake partner. Contract volumes, prices and durations are not disclosed, so the strength of that demand cannot be measured from public material. Offtake interest from a named buyer is encouraging, but it is not the same as take-or-pay revenue that covers fixed costs.
Verdict: a real plant, an unproven margin
Delivering an industrial plant on budget is a genuine step, and a named feed buyer adds some weight. But the evidence stops at commissioning. The bet behind this raise is that a lean, electric, low-capex plant can earn a margin at industrial scale. Until Volare publishes utilisation, cost per tonne and contract terms, treat its plans for further facilities as ambition rather than forecast, and treat the funding totals as unconfirmed.
- What did Volare open and how big is it?
- Volare opened Volare 01 in Pori, Finland, a 10,000 m² facility. Tech.eu reports it targets up to 5,000 tonnes of insect protein a year, produced from black soldier fly larvae.
- How much did Volare raise and from whom?
- Tech.eu reports €7.1 million in new funding through Springvest, backed by new and existing investors including Maki.vc. The coverage does not say whether it is equity, debt or a grant, so the terms are undisclosed.
- Does the factory prove the business works?
- Not yet. The plant reportedly met its schedule and budget, but commissioning is not profitability. Production volumes, cost per tonne and contract terms have not been published.